• COVID-19
  • Allergies and Infant Formula
  • Pharmacology
  • Telemedicine
  • Drug Pipeline News
  • Influenza
  • Allergy, Immunology, and ENT
  • Autism
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious disease
  • Nutrition
  • Neurology
  • Obstetrics-Gynecology & Women's Health
  • Developmental/Behavioral Disorders
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Diabetes
  • Mental Health
  • Oncology
  • Psychiatry
  • Animal Allergies
  • Alcohol Abuse
  • Rheumatoid Arthritis
  • Sexual Health
  • Pain

Developmental screening via phone increases referrals

Publication
Article
Contemporary PEDS JournalVol 36 No 6
Volume 36
Issue 6

Young children whose parents are screened via telephone about their offspring’s development are far more likely to be referred for evaluation and to receive services than children who receive usual care from their primary care provider (PCP), a randomized trial involving 152 youngsters found.

Young children whose parents are screened via telephone about their offspring’s development are far more likely to be referred for evaluation and to receive services than children who receive usual care from their primary care provider (PCP), a randomized trial involving 152 youngsters found.

Included in the study were children aged from 12 to 42 months who received well-child care at a community health center that primarily serves Hispanic families. Half the group received usual care while the parents of the other half (intervention group) were connected with a trained care coordinator who conducted developmental screening over the phone, using the Parental Evaluation of Development Status Online system. The coordinators were part of a Los Angeles County program (211LA) to detect and address early childhood developmental and behavioral concerns among families who call 2-1-1, a national telephone access number for connecting people to local health and human services.

Based on their assessment of developmental risk during the phone call, the care coordinators made referrals to intervention services and followed up with the families, usually about 15, 30, and 60 days after initial contact, to assist with connecting to evaluations and services. Coordinators also connected families with other services, such as transportation, housing, food, and utility assistance to address any barriers to getting help.

After 6 months, significantly more children in the intervention group than those receiving usual care were referred (32% vs 9%) and were receiving more services (16% vs 1%). These differences between the 2 groups remained even after adjustment for age, sex, and primary language.

To get a better handle on relevant “usual care” at the health center, investigators reviewed the medical records of 142 other children aged from 12 to 42 months who had well-child care during the 6 months before the study started. The review showed that although almost all children had documented developmental surveillance, only 4% had been screened using a structured, validated screening tool (Nelson BB, et al. Pediatrics. 2019;143(4):e20181064).

Thoughts from Dr Burke

 

I confess to a bit of regret that this process, bypassing the child’s doctor, is more effective in screening and completing referral for development concerns. However, the results, at least in this setting, are impressive and show a real benefit to these children. If this project is taken to scale, I hope that the child’s physician is kept in the loop when the screen is abnormal and after referral and evaluation are complete. These patients and their families will need an ally in dealing with the developmental conditions that are identified.

Related Videos
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
Scott Ceresnak, MD
Importance of maternal influenza vaccination recommendations
Reducing HIV reservoirs in neonates with very early antiretroviral therapy | Deborah Persaud, MD
Samantha Olson, MPH
Deborah Persaud, MD
Ari Brown, MD, FAAP | Pediatrician and CEO of 411 Pediatrics; author, baby411 book series; chief medical advisor, Kabrita USA.
© 2024 MJH Life Sciences

All rights reserved.